• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

    4/28/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $INMD alert in real time by email

    In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares 

    YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025.

    INMODE Logo

    First Quarter 2025 Highlights:

    • Quarterly GAAP revenues of $77.9 million, compared to $80.3 million in the first quarter of 2024.
    • Quarterly revenues from consumables and service of $20.2 million, a decrease of 10% compared to the first quarter of 2024.
    • GAAP operating income of $15.6 million, *non-GAAP operating income of $18.1 million.
    • Total cash position of $512.9 million as of March 31, 2025, including cash and cash equivalents, marketable securities and short-term bank deposits.
    • In April 2025, completed the repurchase of 6.95 million ordinary shares, returning $127 million of capital to shareholders year-to-date through a share repurchase program.

     

    U.S. GAAP Results

    (U.S. dollars in thousands, except for per share data)



    Q1 2025

    Q1 2024

    Revenues

    $77,874

    $80,284

    Gross Margins

    78 %

    80 %

    Net Income

    $18,201

    $23,696

    Earnings per Diluted Share

    $0.26

    $0.28

    *Non-GAAP Results

    (U.S. dollars in thousands, except for per share data)



      Q1 2025

    Q1 2024

    Gross Margins

    79 %

    80 %

    Net Income

    $21,395

    $27,679

    Earnings per Diluted Share

    $0.31

    $0.32

    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.

    Management Comments

    "In Q1 2025, our performance reflected continued pressure from a challenging macroeconomic environment and weakened consumer demand," said Moshe Mizrahy, Chief Executive Officer of InMode. "While these external factors impacted results, we remain focused on executing our strategy. This includes driving operational excellence, investing in innovation, and pursuing disciplined capital allocation."

    "We are pleased with our international performance in Q1, particularly in Europe, where we achieved record revenue despite ongoing market headwinds. Looking forward, we believe the recent launch of our OptimasMAX, and Ignite platforms reinforces our commitment to innovation while offering the gold standard technology in aesthetics," Mizrahy concluded.

    Yair Malca, Chief Financial Officer of InMode, added, "Our strong balance sheet provides the stability and flexibility to navigate near-term challenges while continuing to invest in our long-term growth and recruit the best talent in the industry. We're pleased to report that, earlier this month, we completed our fifth share repurchase program of 6.95 million shares approved by our board of directors in February 2025, for a total of $127 million, underscoring our commitment to disciplined capital allocation and returning value to shareholders. In fact, our total capital return to shareholders in the past 12 months was more than $412 million, executed via share repurchases representing approximately 27% of our share capital.

    "As always, we continue to explore all avenues for disciplined capital allocation, including additional share repurchases, potential dividends, and strategic M&A opportunities. Our approach remains focused on maximizing long-term shareholder value while maintaining a strong and flexible balance sheet. In addition, international markets accounted for a larger share of total revenue while the U.S. continued to experience challenging headwinds, resulting in a 4%–5% decline in operating margins. We anticipate this trend will persist through the end of the year. Lastly, with U.S. tariffs at their current levels at 10%, we expect an impact of approximately 2%–3% on gross margins," Malca concluded.

    First Quarter 2025 Financial Results

    Total GAAP revenues for the first quarter of 2025 were $77.9 million, a decrease of 3% compared to $80.3 million in first quarter of 2024.

    GAAP gross margin for the first quarter of 2025 was 78%, compared to a gross margin of 80% for the first quarter of 2024. *Non-GAAP gross margin for the first quarter of 2025 was 79%, compared to a gross margin of 80% for the first quarter of 2024.

    GAAP operating margin for the first quarter of 2025 was 20%, compared to 23% in the first quarter of 2024. *Non-GAAP operating margin for the first quarter of 2025 was 23% compared to 27% for the first quarter of 2024. This decrease was primarily attributable to the increase in cost of goods and marketing activity due to launch of new products.

    InMode reported GAAP net income of $18.2 million, or $0.26 per diluted share, in the first quarter of 2025, compared to $23.7 million, or $0.28 per diluted share, in the first quarter of 2024. On a *non-GAAP basis, InMode reported net income of $21.4 million, or $0.31 per diluted share, in the first quarter of 2025, compared to $27.7 million, or $0.32 per diluted share, in the first quarter of 2024.

    As of March 31, 2025, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $512.9 million.

    2025 Financial Outlook

    Management provided an outlook for the full year of 2025 ending December 31, 2025. Based on our current estimates, management expects:

    • Revenues between $395 to $405 million
    • *Non-GAAP gross margin between 78% and 80%, compared to previous guidance of 80% to 82%
    • *Non-GAAP income from operations to be between $101 million and $106 million, compared to previous guidance of $130 million to $135 million
    • *Non-GAAP earnings per diluted share between $1.64 to $1.68, compared to previous guidance of $1.95 to $1.99

    This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.

    The Current Situation in Israel

    Regarding the current situation in Israel, Israel and Hamas agreed to a ceasefire agreement; the first phase of such ceasefire began in January 2025. During March 2025, the ceasefire collapsed. Since its collapse, fighting has been carried out at low intensity, amid international attempts to end the war. We remain confident in our ability to continue our R&D and manufacturing activities while maintaining the safety and well-being of our employees.

    Use of Non-GAAP Financial Measures

    In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

    Conference Call Information

    Mr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer will host a conference call today, April 28, 2025, at 8:30 a.m. Eastern Time to discuss the first quarter 2025 financial results.

    The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10198516/fede138cb8.

    Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

    For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

    U.S. Toll-Free Dial-in Number: 1-833-316-0562

    Israel Toll- Free Dial-in Number: 1-80-921-2373

    International Dial-in Number: 1-412-317-5736

    Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=jNwaTGkH

    At:

    8:30 a.m. Eastern Time

    5:30 a.m. Pacific Time

    The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from April 28, 2025, at 12 p.m. Eastern Time to May 12, 2025, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

    Replay Dial-in U.S TOLL-FREE: 1-877-344-7529

    Replay Dial-in Canada TOLL-FREE: 1-855-669-9658

    Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088

    Replay Pin Number: 3039661

    To access the replay using an international dial-in number, please select the link below: https://services.choruscall.com/ccforms/replay.html

    A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

    About InMode

    InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

    Forward-Looking Statements 

    The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

     

    Company Contact:

    Yair Malca

    Chief Financial Officer

    Phone: (949) 305-0108

    Email: [email protected]

    Investor Relations Contact:

    Miri Segal

    MS-IR LLC

    Email: [email protected]

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    Three months ended

    M
    arch 31,



    2025

    2024

    REVENUES

    77,874

    80,284

    COST OF REVENUES

    16,963

    16,365

    GROSS PROFIT

    60,911

    63,919

    OPERATING EXPENSES:





    Research and development

    2,895

    3,518

    Sales and marketing

    39,727

    39,795

    General and administrative

    2,671

    2,514

    TOTAL OPERATING EXPENSES

    45,293

    45,827

    OPERATIONS INCOME

    15,618

    18,092

    Finance income, net

    6,859

    7,984

    INCOME BEFORE INCOME TAXES

    22,477

    26,076

    INCOME TAXES

    4,276

    2,380

    NET INCOME

    18,201

    23,696







     EARNINGS PER SHARE:





    Basic

    0.26

    0.28

    Diluted

    0.26

    0.28

    WEIGHTED AVERAGE NUMBER OF SHARES

    OUTSTANDING USED IN COMPUTATION OF

    EARNINGS PER SHARE (in thousands)





    Basic

    68,760

    84,523

    Diluted

    69,435

    85,965

     

    INMODE LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    March 31,

    2025

    December 31,

    2024

    Assets





    CURRENT ASSETS:





    Cash and cash equivalents

    145,948

    155,329

    Marketable securities

    224,457

    267,688

    Short-term bank deposits

    142,520

    173,455

    Accounts receivable, net of allowance for credit losses

    32,367

    36,335

    Prepaid expense and other receivables

    25,564

    22,097

    Inventories

    63,781

    59,548

             TOTAL CURRENT ASSETS

    634,637

    714,452

        NON-CURRENT ASSETS:





    Accounts receivable, net of allowance for credit losses

    2,694

    3,176

    Deferred income tax asset

    55,338

    56,285

    Operating lease right-of-use assets

    9,133

    8,732

    Property and equipment, net

    2,233

    2,322

    Other investments

    700

    700

    TOTAL NON-CURRENT ASSETS

    70,098

    71,215

    TOTAL ASSETS

    704,735

    785,667

    Liabilities and shareholders' equity





    CURRENT LIABILITIES:





    Accounts payable

    15,052

    13,782

    Contract liabilities

    15,861

    16,755

    Other liabilities

    41,745

    39,314

    TOTAL CURRENT LIABILITIES

    72,658

    69,851

        NON-CURRENT LIABILITIES:





    Contract liabilities

    3,393

    3,336

    Other liabilities

    3,668

    3,356

    Operating lease liabilities

    5,588

    5,311

    TOTAL NON-CURRENT LIABILITIES

    12,649

    12,003

    TOTAL LIABILITIES

    85,307

    81,854







    TOTAL SHAREHOLDERS' EQUITY

    619,428

    703,813

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    704,735

    785,667

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended

    March 31,



    2025

    2024

    CASH FLOWS FROM OPERATING ACTIVITIES:





    Net income

    18,201

    23,696

    Adjustments required to reconcile net income to net cash provided by

    operating activities:





    Depreciation and amortization

    174

    165

    Share-based compensation expenses

    2,518

    3,983

    Change in allowance for credit losses of trade receivable

    (94)

    187

    Loss (gains) on marketable securities, net

    (2)

    29

    Finance income, net

    (1,574)

    (4,757)

    Deferred income taxes, net

    896

    (37)

    Changes in operating assets and liabilities:





    Decrease in accounts receivable

    4,544

    9,308

    Increase in other receivables

    (3,532)

    (2,669)

    Increase in inventories

    (4,233)

    (6,507)

    Increase (decrease) in accounts payable

    1,270

    (743)

    Decrease in other liabilities

    (3,287)

    (7,803)

    Increase (decrease) in contract liabilities (current and non-current)

    (837)

    9,262

    Net cash provided by operating activities

    14,044

    24,114

    CASH FLOWS FROM INVESTING ACTIVITIES:





    Investment in short-term deposits

    -

    (31,297)

    Proceeds from short-term deposits

    31,297

    -

    Purchase of fixed assets

    (85)

    (112)

    Purchase of marketable securities

    (20,877)

    (121,564)

    Proceeds from sale of marketable securities

    3,003

    13,465

    Proceeds from maturity of marketable securities

    62,147

    92,118

    Net cash provided by (used in) investing activities

    75,485

    (47,390)

    CASH FLOWS FROM FINANCING ACTIVITIES:





      Repurchase of ordinary shares

    (99,960)

    -

      Exercise of options

    494

    234

    Net cash provided by (used in) financing activities

    (99,466)

    234

    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH

    EQUIVALENTS

    556

    (439)

    NET DECREASE IN CASH AND CASH EQUIVALENTS

    (9,381)

    (23,481)

    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

    155,329

    144,411

    CASH AND CASH EQUIVALENTS AT END OF PERIOD

    145,948

    120,930

     

    INMODE LTD.

    CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    Three months ended

    M
    arch 31,

    2025

    2024

    Revenues by Category:



















    Capital Equipment revenues - United

    States

    29,542

    38 %

    30,859

    38 %

    Capital Equipment revenues -

    International

    28,133

    36 %

    26,923

    34 %

    Total Capital Equipment revenues

    57,675

    74 %

    57,782

    72 %

    Consumables and service revenues

    20,199

    26 %

    22,502

    28 %

    Total Revenue

    77,874

    100 %

    80,284

    100 %













     



    Three months ended

    M
    arch 31,

    2025

    2024



    %

    %



    United

    States



    International

    Total

    United

    States

    International

    Total

    Revenues by Technology:













    Minimally Invasive

    93

    79

    87

    87

    80

    84

    Hands-Free

    3

    2

    3

    8

    3

    5

    Non-Invasive

    4

    19

    10

    5

    17

    11



    100

    100

    100

    100

    100

    100

     

    INMODE LTD.



    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF



    INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 



    (U.S. dollars in thousands, except for per share data)



    (Unaudited)





     

    Three months ended March 31, 2025

     

    Three months ended March 31, 2024



     

     

    GAAP

     

    Share Based

    Compensation

     

     

    Non-GAAP

     

     

    GAAP

     

    Share Based

    Compensation

     

     

    Non-GAAP



    REVENUES

    77,874

    -

    77,874

    80,284

    -

    80,284



    COST OF REVENUES

    16,963

    (310)

    16,653

    16,365

    (409)

    15,956



    GROSS PROFIT

    60,911

    310

    61,221

    63,919

    409

    64,328



    OPERATING EXPENSES:















    Research and development

    2,895

    (222)

    2,673

    3,518

    (428)

    3,090



    Sales and marketing

    39,727

    (1,763)

    37,964

    39,795

    (2,883)

    36,912



    General and administrative

    2,671

    (223)

    2,448

    2,514

    (263)

    2,251



    TOTAL OPERATING

    EXPENSES

     

    45,293

     

    (2,208)

     

    43,085

     

    45,827

     

    (3,574)

     

    42,253



    OPERATIONS INCOME

    15,618

    2,518

    18,136

    18,092

    3,983

    22,075



    Finance income, net

    6,859

    -

    6,859

    7,984

    -

    7,984



    INCOME BEFORE INCOME TAXES

    22,477

    2,518

    24,995

    26,076

    3,983

    30,059



    INCOME TAXES

    4,276

    (676)

    3,600

    2,380

    -

    2,380



    NET INCOME

    18,201

    3,194

    21,395

    23,696

    3,983

    27,679



















    EARNINGS PER SHARE:















    Basic

    0.26



    0.31

    0.28



    0.33



    Diluted

    0.26



    0.31

    0.28



    0.32



    WEIGHTED AVERAGE NUMBER OF

    SHARES OUTSTANDING USED IN

    COMPUTATION OF EARNINGS PER

    SHARE (in thousands)















    Basic

    68,760



    68,760

    84,523



    84,523



    Diluted

    69,435



    69,611

    85,965



    86,563



     

    Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

    Cision View original content:https://www.prnewswire.com/news-releases/inmode-reports-first-quarter-2025-financial-results-quarterly-revenue-of-77-9-million-represents-3-year-over-year-decrease-302439156.html

    SOURCE InMode Ltd.

    Get the next $INMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INMD

    DatePrice TargetRatingAnalyst
    4/29/2025Buy → Neutral
    BTIG Research
    4/28/2025$22.00 → $16.00Outperform → Neutral
    Robert W. Baird
    10/17/2024$25.00Buy
    BTIG Research
    7/23/2024$21.00 → $19.00Buy → Hold
    Jefferies
    11/3/2023$52.00 → $24.00Buy → Neutral
    UBS
    10/13/2023$55.00 → $22.00Buy → Hold
    Canaccord Genuity
    3/29/2023$40.00Buy
    UBS
    2/17/2023Buy → Hold
    Needham
    More analyst ratings

    $INMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

      YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public letter dated May 9, 2025. The letter can be viewed here The full text of the letter follows: May 28, 2025 Mr. Pedro EscuderoCEO and CIODOMA, Perpetual Capital Management LLC Dear Mr. Escudero, This letter is in response to your letter dated May 9, 2025. First, I would like to thank you for voting for me to be re-elected to the Board of Directors. I really appreciate your vote of confidence and trust. I unde

      5/28/25 8:30:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology

      YOKNEAM, Israel, May 20, 2025 /CNW/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, is pleased to announce Health Canada certification of IgniteRF, an advanced platform offering a comprehensive suite of minimally invasive radiofrequency solutions for the face and body.     IgniteRF is equipped with nine proprietary technologies, including the new QuantumRF, Morpheus8 Burst and Burst Deep, BodyTite Turbo, and FaceTite Turbo handpieces. This advanced complement of technologies leverages the heritage and efficacy of clinically proven bipolar radiofrequency to address consumer demand for minimal downtime procedures that deliver natural-looking results

      5/20/25 9:17:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

      Believes the Board Should Immediately Resume and Accelerate Buybacks Asserts Board Should Remove Moshe Mizrahy as CEO of the Company MIAMI, May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to continue its stock repurchase program and to replace its CEO.  The letter can be downloaded here The full text of the letter follows: May 9th, 2025 To the Board Members of InMode: For over a year, we have communicated p

      5/9/25 8:22:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $INMD
    SEC Filings

    See more
    • SEC Form 6-K filed by InMode Ltd.

      6-K - InMode Ltd. (0001742692) (Filer)

      5/19/25 7:00:11 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 6-K filed by InMode Ltd.

      6-K - InMode Ltd. (0001742692) (Filer)

      4/28/25 7:00:06 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 6-K filed by InMode Ltd.

      6-K - InMode Ltd. (0001742692) (Filer)

      4/3/25 7:07:38 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $INMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • InMode downgraded by BTIG Research

      BTIG Research downgraded InMode from Buy to Neutral

      4/29/25 8:06:22 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • InMode downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded InMode from Outperform to Neutral and set a new price target of $16.00 from $22.00 previously

      4/28/25 1:56:11 PM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • BTIG Research initiated coverage on InMode with a new price target

      BTIG Research initiated coverage of InMode with a rating of Buy and set a new price target of $25.00

      10/17/24 7:41:34 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $INMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

      SC 13G/A - InMode Ltd. (0001742692) (Subject)

      2/13/24 4:31:18 PM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

      SC 13G/A - InMode Ltd. (0001742692) (Subject)

      2/13/24 4:25:40 PM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by InMode Ltd.

      SC 13G - InMode Ltd. (0001742692) (Subject)

      2/6/24 9:36:39 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $INMD
    Financials

    Live finance-specific insights

    See more
    • DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

      Believes the Board Should Immediately Resume and Accelerate Buybacks Asserts Board Should Remove Moshe Mizrahy as CEO of the Company MIAMI, May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to continue its stock repurchase program and to replace its CEO.  The letter can be downloaded here The full text of the letter follows: May 9th, 2025 To the Board Members of InMode: For over a year, we have communicated p

      5/9/25 8:22:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

      In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares  YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Quarterly GAAP revenues of $77.9 million, compared to $80.3 million in the first quarter of 2024.Quarterly revenues from consumables and service of $20.2 million, a decrease of 10% compared to the first quarter of 2024.GAAP operating income of $15.6 million, *non-GAAP operating income of $18.1 million.Total cash position of $512.9 million as

      4/28/25 7:00:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M

      Conference call to be held on Monday, April 28, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 14, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2025 before the Nasdaq market opens on Monday, April 28, 2025. InMode is currently finalizing its financial results for the first quarter of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of I

      4/14/25 7:00:00 AM ET
      $INMD
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care